Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets.

Biopharmaceutical Computer-assisted modeling Fraction collection Ion exchange chromatography Multidimensional liquid chromatography Screening

Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
May 2022
Historique:
received: 22 12 2021
accepted: 15 02 2022
revised: 10 02 2022
pubmed: 21 4 2022
medline: 27 4 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Bioprocess development of increasingly challenging therapeutics and vaccines requires a commensurate level of analytical innovation to deliver critical assays across functional areas. Chromatography hyphenated to numerous choices of detection has undeniably been the preferred analytical tool in the pharmaceutical industry for decades to analyze and isolate targets (e.g., APIs, intermediates, and byproducts) from multicomponent mixtures. Among many techniques, ion exchange chromatography (IEX) is widely used for the analysis and purification of biopharmaceuticals due to its unique selectivity that delivers distinctive chromatographic profiles compared to other separation modes (e.g., RPLC, HILIC, and SFC) without denaturing protein targets upon isolation process. However, IEX method development is still considered one of the most challenging and laborious approaches due to the many variables involved such as elution mechanism (via salt, pH, or salt-mediated-pH gradients), stationary phase's properties (positively or negatively charged; strong or weak ion exchanger), buffer type and ionic strength as well as pH choices. Herein, we introduce a new framework consisting of a multicolumn IEX screening in conjunction with computer-assisted simulation for efficient method development and purification of biopharmaceuticals. The screening component integrates a total of 12 different columns and 24 mobile phases that are sequentially operated in a straightforward automated fashion for both cation and anion exchange modes (CEX and AEX, respectively). Optimal and robust operating conditions are achieved via computer-assisted simulation using readily available software (ACD Laboratories/LC Simulator), showcasing differences between experimental and simulated retention times of less than 0.5%. In addition, automated fraction collection is also incorporated into this framework, illustrating the practicality and ease of use in the context of separation, analysis, and purification of nucleotides, peptides, and proteins. Finally, we provide examples of the use of this IEX screening as a framework to identify efficient first dimension (

Identifiants

pubmed: 35441858
doi: 10.1007/s00216-022-03982-z
pii: 10.1007/s00216-022-03982-z
doi:

Substances chimiques

Biological Products 0
Peptides 0
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3581-3591

Informations de copyright

© 2022. Merck & Co., Inc., Kenilworth, NJ, USA and its affiliates and Davy Guillarme under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Regalado EL, Haidar Ahmad IA, Bennett R, D’Atri V, Makarov AA, Humphrey GR, et al. The emergence of universal chromatographic methods in the research and development of new drug substances. Acc Chem Res. 2019;52(7):1990–2002.
pubmed: 31198042 doi: 10.1021/acs.accounts.9b00068
Johnson DE. Biotherapeutics: challenges and opportunities for predictive toxicology of monoclonal antibodies. Int J Mol Sci. 2018;19(11):3685.
pmcid: 6274697 doi: 10.3390/ijms19113685
Gautam A, Pan X. The changing model of big pharma: impact of key trends. Drug Discovery Today. 2016;21(3):379–84.
pubmed: 26477304 doi: 10.1016/j.drudis.2015.10.002
Fekete S, Guillarme D, Sandra P, Sandra K. Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem. 2016;88(1):480–507.
pubmed: 26629607 doi: 10.1021/acs.analchem.5b04561
Haidar Ahmad IA, Bennett R, Makey D, Shchurik V, Lhotka H, Mann BF, et al. In silico method development for the reversed-phase liquid chromatography separation of proteins using chaotropic mobile phase modifiers. J Chromatogr B. 2021;1173:122587.
doi: 10.1016/j.jchromb.2021.122587
Camperi J, Goyon A, Guillarme D, Zhang K, Stella C. Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches. Analyst. 2021;146(3):747–69.
pubmed: 33410843 doi: 10.1039/D0AN01963A
Goyon A, D’Atri V, Bobaly B, Wagner-Rousset E, Beck A, Fekete S, et al. Protocols for the analytical characterization of therapeutic monoclonal antibodies. I – non-denaturing chromatographic techniques. J Chromatogr B. 2017;1058:73–84.
doi: 10.1016/j.jchromb.2017.05.010
Losacco GL, DaSilva JO, Liu J, Regalado EL, Veuthey J-L, Guillarme D. Expanding the range of sub/supercritical fluid chromatography: advantageous use of methanesulfonic acid in water-rich modifiers for peptide analysis. J Chromatogr A. 2021;1642:462048.
pubmed: 33744606 doi: 10.1016/j.chroma.2021.462048
Goyon A, Zhang K. Characterization of antisense oligonucleotide impurities by ion-pairing reversed-phase and anion exchange chromatography coupled to hydrophilic interaction liquid chromatography/mass spectrometry using a versatile two-dimensional liquid chromatography setup. Anal Chem. 2020;92(8):5944–51.
pubmed: 32191031 doi: 10.1021/acs.analchem.0c00114
Bennett R, Biba M, Liu J, Haidar Ahmad IA, Hicks MB, Regalado EL. Enhanced fluidity liquid chromatography: a guide to scaling up from analytical to preparative separations. J Chromatogr A. 2019;1595:190–8.
pubmed: 30803788 doi: 10.1016/j.chroma.2019.02.017
Ikegami T. Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: a review based on the separation characteristics of the hydrophilic interaction chromatography phases. J Sep Sci. 2019;42(1):130–213.
pubmed: 30461188 doi: 10.1002/jssc.201801074
Jaag S, Shirokikh M, Lämmerhofer M. Charge variant analysis of protein-based biopharmaceuticals using two-dimensional liquid chromatography hyphenated to mass spectrometry. J Chromatogr A. 2021;1636:461786.
pubmed: 33326927 doi: 10.1016/j.chroma.2020.461786
Periat A, Fekete S, Cusumano A, Veuthey J-L, Beck A, Lauber M, et al. Potential of hydrophilic interaction chromatography for the analytical characterization of protein biopharmaceuticals. J Chromatogr A. 2016;1448:81–92.
pubmed: 27131959 doi: 10.1016/j.chroma.2016.04.056
Piestansky J, Barath P, Majerova P, Galba J, Mikus P, Kovacech B, et al. A simple and rapid LC-MS/MS and CE-MS/MS analytical strategy for the determination of therapeutic peptides in modern immunotherapeutics and biopharmaceutics. J Pharm Biomed Anal. 2020;189:113449.
pubmed: 32622303 doi: 10.1016/j.jpba.2020.113449
Fekete S, Beck A, Veuthey J-L, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015;113:43–55.
pubmed: 25800161 doi: 10.1016/j.jpba.2015.02.037
Abou El Azm N, Fleita D, Rifaat D, Mpingirika EZ, Amleh A, El-Sayed MMH. Production of bioactive compounds from the sulfated polysaccharides extracts of Ulva lactuca: post-extraction enzymatic hydrolysis followed by ion-exchange chromatographic fractionation. Molecules. 2019;24(11):2132.
pmcid: 6600532 doi: 10.3390/molecules24112132
Leblanc Y, Bihoreau N, Chevreux G. Characterization of human serum albumin isoforms by ion exchange chromatography coupled on-line to native mass spectrometry. J Chromatogr B. 2018;1095:87–93.
doi: 10.1016/j.jchromb.2018.07.014
McGinnis AC, Cummings BS, Bartlett MG. Ion exchange liquid chromatography method for the direct determination of small ribonucleic acids. Anal Chim Acta. 2013;799:57–67.
pubmed: 24091375 doi: 10.1016/j.aca.2013.08.040
Mommen GPM, Meiring HD, Heck AJR, de Jong APJM. Mixed-bed ion exchange chromatography employing a salt-free pH gradient for improved sensitivity and compatibility in MudPIT. Anal Chem. 2013;85(14):6608–16.
pubmed: 23772827 doi: 10.1021/ac400995e
Bertoletti L, Regazzoni L, Aldini G, Colombo R, Abballe F, Caccialanza G, et al. Separation and characterisation of beta2-microglobulin folding conformers by ion-exchange liquid chromatography and ion-exchange liquid chromatography–mass spectrometry. Anal Chim Acta. 2013;771:108–14.
pubmed: 23522119 doi: 10.1016/j.aca.2013.01.058
Haidar Ahmad IA, Shchurik V, Nowak T, Mann BF, Regalado EL. Introducing multifactorial peak crossover in analytical and preparative chromatography via computer-assisted modeling. Anal Chem. 2020;92(19):13443–51.
pubmed: 32786491 doi: 10.1021/acs.analchem.0c02807
Ahmed S, Atia NN, Rageh AH. Selectivity enhanced cation exchange chromatography for simultaneous determination of peptide variants. Talanta. 2019;199:347–54.
pubmed: 30952269 doi: 10.1016/j.talanta.2019.02.082
Verscheure L, Cerdobbel A, Sandra P, Lynen F, Sandra K. Monoclonal antibody charge variant characterization by fully automated four-dimensional liquid chromatography-mass spectrometry. J Chromatogr A. 2021;1653:462409.
pubmed: 34325295 doi: 10.1016/j.chroma.2021.462409
Gstöttner C, Klemm D, Haberger M, Bathke A, Wegele H, Bell C, et al. Fast and automated characterization of antibody variants with 4D HPLC/MS. Anal Chem. 2018;90(3):2119–25.
pubmed: 29264912 doi: 10.1021/acs.analchem.7b04372
Füssl F, Trappe A, Carillo S, Jakes C, Bones J. Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry. Anal Chem. 2020;92(7):5431–8.
pubmed: 32105056 doi: 10.1021/acs.analchem.0c00185
Schiavone NM, Bennett R, Hicks MB, Pirrone GF, Regalado EL, Mangion I, et al. Evaluation of global conformational changes in peptides and proteins following purification by supercritical fluid chromatography. J Chromatogr B. 2019;1110–1111:94–100.
doi: 10.1016/j.jchromb.2019.02.012
Li Z, Wang Q, Wang Y, Wang K, Liu Z, Zhang W, et al. An efficient approach based on basic strong cation exchange chromatography for enriching methylated peptides with high specificity for methylproteomics analysis. Anal Chim Acta. 2021;1161:338467.
pubmed: 33896563 doi: 10.1016/j.aca.2021.338467
Patel BA, Pinto NDS, Gospodarek A, Kilgore B, Goswami K, Napoli WN, et al. On-line ion exchange liquid chromatography as a process analytical technology for monoclonal antibody characterization in continuous bioprocessing. Anal Chem. 2017;89(21):11357–65.
pubmed: 28981255 doi: 10.1021/acs.analchem.7b02228
Tsay F-R, Haidar Ahmad IA, Henderson D, Schiavone N, Liu Z, Makarov AA, et al. Generic anion-exchange chromatography method for analytical and preparative separation of nucleotides in the development and manufacture of drug substances. J Chromatogr A. 2019;1587:129–35.
pubmed: 30591245 doi: 10.1016/j.chroma.2018.12.018
Yan Y, Liu AP, Wang S, Daly TJ, Li N. Ultrasensitive characterization of charge heterogeneity of therapeutic monoclonal antibodies using strong cation exchange chromatography coupled to native mass spectrometry. Anal Chem. 2018;90(21):13013–20.
pubmed: 30280893 doi: 10.1021/acs.analchem.8b03773
Losacco GL, Wang H, Ahmad IH, DaSilva J, Makarov AA, Mangion I, et al. Enantioselective UHPLC screening combined with in silico modeling for streamlined development of ultrafast enantiopurity assays. Anal Chem. 2022;94(3):1804–12.
pubmed: 34931812 doi: 10.1021/acs.analchem.1c04585
Haidar Ahmad IA, Makey DM, Wang H, Shchurik V, Singh AN, Stoll DR, et al. In silico multifactorial modeling for streamlined development and optimization of two-dimensional liquid chromatography. Anal Chem. 2021;93(33):11532–9.
pubmed: 34375071 doi: 10.1021/acs.analchem.1c01970
Wang H, Herderschee HR, Bennett R, Potapenko M, Pickens CJ, Mann BF, et al. Introducing online multicolumn two-dimensional liquid chromatography screening for facile selection of stationary and mobile phase conditions in both dimensions. J Chromatogr A. 2020;1622:460895.
pubmed: 32408991 doi: 10.1016/j.chroma.2020.460895
Barhate CL, Joyce LA, Makarov AA, Zawatzky K, Bernardoni F, Schafer WA, et al. Ultrafast chiral separations for high throughput enantiopurity analysis. Chem Commun. 2017;53(3):509–12.
doi: 10.1039/C6CC08512A
Haidar Ahmad IA, Chen W, Halsey HM, Klapars A, Limanto J, Pirrone GF, et al. Multi-column ultra-high performance liquid chromatography screening with chaotropic agents and computer-assisted separation modeling enables process development of new drug substances. Analyst. 2019;144(9):2872–80.
pubmed: 30830135 doi: 10.1039/C8AN02499E
D’Atri V, Murisier A, Fekete S, Veuthey J-L, Guillarme D. Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins. TrAC Trends Anal Chem. 2020;130:115962.
doi: 10.1016/j.trac.2020.115962
De Pra M, Greco G, Krajewski MP, Martin MM, George E, Bartsch N, et al. Effects of titanium contamination caused by iron-free high-performance liquid chromatography systems on peak shape and retention of drugs with chelating properties. J Chromatogr A. 2020;1611:460619.
pubmed: 31668415 doi: 10.1016/j.chroma.2019.460619
Bennett R, Cohen RD, Wang H, Pereira T, Haverick MA, Loughney JW, et al. A selective plate-based assay for trace EDTA analysis via boron trifluoride-methanol derivatization UHPLC-QqQ-MS/MS enabling biologic and vaccine processes. Anal Chem. 2022;94(3):1678–85.
pubmed: 34928586 doi: 10.1021/acs.analchem.1c04224
Guichard N, Fekete S, Guillarme D, Bonnabry P, Fleury-Souverain S. Computer-assisted UHPLC-MS method development and optimization for the determination of 24 antineoplastic drugs used in hospital pharmacy. J Pharm Biomed Anal. 2019;164:395–401.
pubmed: 30439666 doi: 10.1016/j.jpba.2018.11.014
Haidar Ahmad IA, Kiffer A, Barrientos RC, Losacco GL, Singh A, Shchurik V, Wang H, Mangion I, Regalado EL, et al. In Silico Method Development of Achiral and Chiral Tandem Column Reversed-phase Liquid Chromatography for Multicomponent Pharmaceutical Mixtures. Anal Chem. 2022;94:4065–71.
pubmed: 35199987 doi: 10.1021/acs.analchem.1c05551
Makey DM, Shchurik V, Wang H, Lhotka HR, Stoll DR, Vazhentsev A, et al. Mapping the separation landscape in two-dimensional liquid chromatography: blueprints for efficient analysis and purification of pharmaceuticals enabled by computer-assisted modeling. Anal Chem. 2021;93(2):964–72.
pubmed: 33301312 doi: 10.1021/acs.analchem.0c03680
Bennett R, Haidar Ahmad IA, DaSilva J, Figus M, Hullen K, Tsay F-R, et al. Mapping the separation landscape of pharmaceuticals: rapid and efficient scale-up of preparative purifications enabled by computer-assisted chromatographic method development. Org Process Res Dev. 2019;23(12):2678–84.
doi: 10.1021/acs.oprd.9b00351

Auteurs

Gioacchino Luca Losacco (GL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA. gioacchino.luca.losacco@merck.com.

Michael B Hicks (MB)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Jimmy O DaSilva (JO)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Heather Wang (H)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Miraslava Potapenko (M)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Fuh-Rong Tsay (FR)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Imad A Haidar Ahmad (IAH)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Ian Mangion (I)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA.

Davy Guillarme (D)

School of Pharmaceutical Sciences, University of Geneva, CMU, Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.

Erik L Regalado (EL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ, 07065, USA. erik.regalado@merck.com.

Articles similaires

Databases, Protein Protein Domains Protein Folding Proteins Deep Learning
Animals Huntington Disease Mitochondria Neurons Mice
Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2
Humans Computational Biology ROC Curve Algorithms Proteins

Classifications MeSH